Laser thermal ablation with a non-cooled laser fiber-a phase 1 clinical trial in glioblastoma and astrocytoma grade 4
Neuro-Oncology Advances · 10.11.2026
DOI: 10.1093/noajnl/vdag273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 10.11.2026. Verfasst von Irena Grubor und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Laser interstitial thermal therapy (LITT) is an alternative to open surgery for brain tumors. Clinically available LITT systems use different cooling systems that may impose additional risks and logistics. This is the first open-label phase 1 clinical investigation that explores the safety, feasibility and usability of the non-cooled Prism laser system for ablation of high-grade gliomas.
Methods
This is a single-center prospective study at the Department of Neurosurgery in Lund, Sweden. Patients with primary or recurrent high-grade glioma were included after informed consent. Patients 18-80 years with lesions < 10 cc were eligible. Single or multiple ablations were performed in a 3T MR suite using a MR compatible navigation system (ClearPoint® Neuro Navigation System) together with a new uncooled laser fiber, laser unit and MR thermometry. Functional outcomes were assessed at baseline and at 3 months.
Results
All 14 patients included completed the study. Three patients with newly diagnosed glioblastoma and 11 with recurrent glioblastoma or grade 4 astrocytoma were treated with single or multiple laser thermal ablations. Median extent of ablation was 195%. Out of 22 AEs, 7 were neurological, all of which were graded as mild or moderate. The only procedure-related SAE was a pulmonary embolism that was resolved. None of the adverse events were device related.
Conclusion
The workflow was safe and feasible, with usability of the laser rated highly. Extent of ablation was high and exploratory analyses showed no statistically significant changes in quality of life, neurological and cognitive function at 3 months.
Zitieren
APA
Grubor, I., Bjartmarz, H., Siemund, R., Edvardsson, C., Bengzon, J., & Siesjö, P. (2026). Laser thermal ablation with a non-cooled laser fiber-a phase 1 clinical trial in glioblastoma and astrocytoma grade 4. Neuro-Oncology Advances. https://doi.org/10.1093/noajnl/vdag273
Vancouver
Grubor I, Bjartmarz H, Siemund R, Edvardsson C, Bengzon J, Siesjö P. Laser thermal ablation with a non-cooled laser fiber-a phase 1 clinical trial in glioblastoma and astrocytoma grade 4. Neuro-Oncology Advances. 2026. doi:10.1093/noajnl/vdag273
BibTeX
@article{Grubor2026,
author = {Grubor, Irena and Bjartmarz, Hjalmar and Siemund, Roger and Edvardsson, Charlotte and Bengzon, Johan and Siesjö, Peter},
title = {Laser thermal ablation with a non-cooled laser fiber-a phase 1 clinical trial in glioblastoma and astrocytoma grade 4},
journal = {Neuro-Oncology Advances},
year = {2026},
doi = {10.1093/noajnl/vdag273}
}
EUVIMED